Table 5 Excretion rates of urine arsenic (uAsCr, μmol/mmol), median (IQR).

From: Long-term outcome of children with acute promyelocytic leukemia: a randomized study of oral versus intravenous arsenic by SCCLG-APL group

 

Total

ATO group

RIF group

p

Before arsenic

N = 139

0.0140

(0.0082, 0.0366)

N = 69

0.0160

(0.0104, 0.0385)

N = 70

0.0128

(0.0066, 0.0343)

0.098

Before maintenance

N = 136

0.1441a

(0.0941, 0.3869)

N = 66

0.1423

(0.1062, 0.3918)

N = 70

0.1481

(0.0750, 0.3766)

0.418

End of maintenance

N = 72

0.0177b

(0.0104, 0.0274)

N = 37

0.0180

(0.0114, 0.0286)

N = 35

0.0158

(0.0098, 0.0253)

0.297

  1. Compare with the excretion rates of urine arsenic before arsenic treatment: ap < 0.001, bp < 0.05.
Back to article page